Ticker brief
RNA
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
6
authors 14d
5
crowd 14d
+0.9σ
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-10-08 → 2026-10-15 · now +0.40 (−1 bearish … +1 bullish)
Who spoke5
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @Briefingcom | B | -2.26 | 2 | +0.08 |
| @BioStocks | C | -1.77 | 1 | -0.15 |
| @OpenOutcrier | C | · | 1 | -0.15 |
| @BiopharmIQ | B | · | 1 | -0.10 |
| @semodough | C | -1.06 | 1 | +0.40 |
Recent signals6of 6 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-15 | @semodough | +0.40 | Cantor says RNA is undervalued and calls this a strong time to own shares ahead of clinical data. | · | tweet ↗ |
| 2026-10-08 | @BiopharmIQ | -0.10 | Biotech roundup reports acquisition, trial approval, study and financing events. | · | tweet ↗ |
| 2026-10-08 | @OpenOutcrier | -0.15 | Reports a $50M private placement by Atrium Therapeutics. | · | tweet ↗ |
| 2026-10-08 | @Briefingcom | -0.15 | Company announced a $50M private placement funding operations through 2028. | · | tweet ↗ |
| 2026-10-08 | @Briefingcom | +0.30 | Lists the largest premarket gaps; output retains the first six tickers under the schema cap. | · | tweet ↗ |
| 2026-10-08 | @BioStocks | -0.15 | Avidity announced a $50 million PIPE priced at $7.93 per share. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.